Objective: To discuss current and potential treatment options for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA). Data Sources: A MEDLINE search (1966-January 2007 ...

aureus. Fortunately ... and tigecycline are representants of three novel antibacterial classes for the treatment of infections caused by MRSA. In the following section novel antibacterials ...

Following Pope Francis’ diagnosis of bilateral pneumonia, respiratory doctors are speaking about the condition. The Vatican ...

"A prime example is dalbavancin, a treatment option for patients infected with methicillin-resistant Staphylococcus aureus ... aureus can be a potent cause of skin and bloodstream infections ...

Researchers have revealed how Staphylococcus aureus bacteria ... such as pneumonia or even life-threatening sepsis. Antibiotics are used routinely to tackle S. aureus infections, but some strains ...

compared to patients who received no treatment or a placebo. Staph infections can cause significant complications in hospitalized patients: pneumonia, surgical wound infections, urinary tract ...

Staphylococcus aureus, a common cause of infections especially, has developed resistance to multiple drugs, complicating treatment efforts and increasing the incidence of nosocomial infections.

A nasal wash product sold under the brand name SinuCleanse has been recalled due to contamination with Staphylococcus aureus bacteria ... and low blood pressure. Treatment involves antibiotics ...

Staphylococcal ... swab can usually isolate S. aureus in children and adults. Although uncommon, a skin biopsy (removing a ...

Testing market is projected to grow from USD 4.3 billion in 2025 to USD 6.5 billion by 2035, registering a CAGR of 4.2%. The ...